SCHEMBL23805897

SCHEMBL23805897

CC(C)(C(=O)c1ccc2c(c1)Cc1ccccc1-2)N1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRD5A2 P31213 2/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ TSHR P16473 2/20 0.52
▸ MAPK1 P28482 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ NPC1 O15118 2/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ TP53 P04637 1/20 0.48
▸ HTR2C P28335 2/20 0.46
▸ HTR2B P41595 2/20 0.46
▸ DRD2 P14416 2/20 0.46
▸ ADRA1D P25100 1/20 0.46
▸ HTR2A P28223 1/20 0.46
▸ HTR7 P34969 1/20 0.46
▸ ADRA1A P35348 1/20 0.46
▸ ADRA1B P35368 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MAPT P10636 3/20 0.43
▸ CYP1A2 P05177 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22355416 0.94 ALDH1A1 (0.58) SRD5A2ALDH1A1TSHRMAPK1SMN1; SMN2
SCHEMBL10941099 0.89 SMN1; SMN2 (0.49) SRD5A2ALDH1A1TSHRMAPK1SMN1; SMN2
SCHEMBL10943297 0.89 ALDH1A1 (0.49) SRD5A2ALDH1A1TSHRMAPK1SMN1; SMN2
SCHEMBL10943047 0.85 ALDH1A1 (0.54) ALDH1A1TSHRMAPK1SMN1; SMN2NPC1
SCHEMBL10942634 0.85 ALDH1A1 (0.54) ALDH1A1TSHRMAPK1SMN1; SMN2NPC1
SCHEMBL23805891 0.84 SRD5A2 (0.47) SRD5A2ALDH1A1TSHRMAPK1SMN1; SMN2
SCHEMBL9681708 0.84 SMN1; SMN2 (0.49) SRD5A2ALDH1A1TSHRMAPK1SMN1; SMN2
SCHEMBL21024772 0.84 ALDH1A1 (0.49) ALDH1A1TSHRMAPK1SMN1; SMN2NPC1
SCHEMBL9681596 0.83 SMN1; SMN2 (0.50) ALDH1A1TSHRMAPK1SMN1; SMN2RAB9A
SCHEMBL22355383 0.82 ALDH1A1 (0.47) ALDH1A1TSHRMAPK1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023120268-A1 PHOTOSENSITIVE COLORED RESIN COMPOSITION, COLOR FILTER, AND DISPLAY DEVICE 株式会社DNPファインケミカル 2023-06-29 — — WO disclosed
WO-2023074411-A1 PHOTOSENSITIVE COLORED RESIN COMPOSITION, COLOR FILTER AND DISPLAY DEVICE 株式会社DNPファインケミカル 2023-05-04 — — WO disclosed
US-11118065-B2 Fluorenylaminoketone photoinitiator, preparation method thereof, and UV photocurable composition containing same CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD. (CN) 2021-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11118065-B2 Fluorenylaminoketone photoinitiator, preparation method thereof, and UV photocurable composition containing same TRPA1, TYR, PKLR SRD5A2 1467/4885ALDH1A1 136/4885TSHR 3252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback